Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

What is the market price of Anamorelin?

In 2021, Japan launched Anamorelin, the world's first drug specifically for the treatment of cachexia. By mimicking the effects of ghrelin, the patient's appetite and body ···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：232
Anamorelin's latest prices?

Anamorelin is the world's first drug specifically for the treatment of cachexia, which increases appetite and improves body weight and muscle mass by activating ghrelin recepto···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：183
What is the latest price of Anamorelin in 2024?

In 2021, Ono Pharmaceutical of Japan launched Anamorelin, a ghrelin receptor agonist that can effectively increase patients' appetite and weight. This drug significantly improv···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：253
Who is Anamorelin for?

Anamorelin is the first cachexia treatment drug launched in Japan in 2021, which is able to stimulate appetite and increase weight by mimicking ghrelin. This ghrelin receptor agoni···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：203
Who is Anamorelin suitable for?

Launched in Japan in 2021, anamoline is the world's first drug specifically for the treatment of cachexia; As a ghrelin receptor agonist, it is able to increase the patient'···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：204
What diseases can Anamorelin treat?

Anamorelin is the world's first drug specifically for the treatment of cachexia, launched in Japan in 2021, which significantly improves patients' appetite and weight by ac···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：239
What is the dosage of Anamorelin?

In 2021, Anamorelin was launched in Japan, becoming the world's first drug specifically for the treatment of cachexia. It significantly increases the patient's appetite and···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：173
Which drugs interact with Mitotane

Designed for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, Mitotane is distinguished by its precise regulation and inhibition of adrenal c···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：179
What are the drug interactions of Mitotane?

Mitotane was developed to address inoperable adrenal cortical carcinoma, hyperplasia, and tumor-induced hypercortisolism, and its core mechanism is the careful regulation and inhib···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：175
What to look out for when using Mitotane

Mitotaneis specific for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced cortisol hyperactivity, and its essence lies in the precise inhibition of adrenal cort···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：223
What are the daily precautions for Mitotane

Mitotane is specifically developed for the treatment of inoperable adrenal cortical carcinoma, hyperplasia, and neoplastic hypercortisolism, and its core mechanism of action is to ···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：200
What are the precautions for using Mitotane?

Mitotane is specifically designed for the treatment of inoperable adrenal carcinoma, hyperplasia, and tumor-induced cortisol excess, and its core efficacy lies in the suppression o···【more】
Article source：Captain MedicineRelease date：2024-08-20Recommended：221

home page previous 36 36/51 next last page

News

Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：3172024-09-07
The FDA has approved pirtobrutinib for the treatment of chronic lymphocytic leukemia (CLL) and small
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】

Recommended：132025-04-12
Combination therapy of tucatinib and T-DM1 significantly improves progression-free survival in patie
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】

Recommended：232025-01-12
The Cure SMA Foundation congratulates the FDA on the broad approval of Itvisma for the treatment of
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】

Recommended：272025-27-11
EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】

Recommended：3062025-13-01
ctDNA and beyond to serve immunotherapy
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】

Recommended：2712025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】

Recommended：3522024-30-12
The EMA recommends expanding the indication for osimertinib
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】

Recommended：2492024-24-12

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More